IN2012MU00206A - - Google Patents

Download PDF

Info

Publication number
IN2012MU00206A
IN2012MU00206A IN206MU2012A IN2012MU00206A IN 2012MU00206 A IN2012MU00206 A IN 2012MU00206A IN 206MU2012 A IN206MU2012 A IN 206MU2012A IN 2012MU00206 A IN2012MU00206 A IN 2012MU00206A
Authority
IN
India
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN206MU2012 priority Critical patent/IN2012MU00206A/en
Priority to US13/745,010 priority patent/US9283270B2/en
Publication of IN2012MU00206A publication Critical patent/IN2012MU00206A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IN206MU2012 2012-01-20 2012-01-20 IN2012MU00206A (en:Method)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN206MU2012 IN2012MU00206A (en:Method) 2012-01-20 2012-01-20
US13/745,010 US9283270B2 (en) 2012-01-20 2013-01-18 Method for stabilization of biological molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN206MU2012 IN2012MU00206A (en:Method) 2012-01-20 2012-01-20

Publications (1)

Publication Number Publication Date
IN2012MU00206A true IN2012MU00206A (en:Method) 2013-08-09

Family

ID=48945734

Family Applications (1)

Application Number Title Priority Date Filing Date
IN206MU2012 IN2012MU00206A (en:Method) 2012-01-20 2012-01-20

Country Status (2)

Country Link
US (1) US9283270B2 (en:Method)
IN (1) IN2012MU00206A (en:Method)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX364644B (es) 2012-11-21 2019-05-03 Serum Inst India Ltd Produccion de altos rendimientos de polisacaridos bacteriales.
CN108025053A (zh) * 2015-04-16 2018-05-11 创赏有限公司 百日咳杆菌免疫原性的疫苗组合物
EP3307307A4 (en) 2015-06-09 2019-05-01 The Board of Regents of the University of Oklahoma COMPOSITIONS AND TREATMENTS FOR HAEMOPHILUS INFLUENZAE
WO2017040885A1 (en) 2015-09-03 2017-03-09 The Board Of Regents Of The University Of Oklahoma Peptide inhibitors of clostridium difficile tcdb toxin
MX2019002489A (es) 2016-09-02 2019-10-21 Sanofi Pasteur Inc Vacuna contra neisseria meningitidis.
WO2019050818A1 (en) 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. METHODS OF FORMULATING PNEUMOCOCCAL POLYSACCHARIDES FOR CONJUGATION TO A CARRIER PROTEIN
US11400162B2 (en) * 2017-02-24 2022-08-02 Merck Sharp & Dohme Llc Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein
CN107828360A (zh) * 2017-11-16 2018-03-23 西安长峰机电研究所 一种常温固化固体火箭发动机喷管结构粘接剂
AU2019254473A1 (en) * 2018-04-16 2020-12-03 Merck Patent Gmbh Additives for protein formulations to improve thermal stability
JOP20200214A1 (ar) * 2019-09-03 2021-03-03 Serum Institute Of India Pvt Ltd تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها
NL2023863B1 (en) * 2019-09-20 2021-05-25 Univ Griffith Protein particles and uses thereof
JP7630603B2 (ja) 2020-08-10 2025-02-17 インベントプライズ・インコーポレイテッド 出現血清型24fを含む多価肺炎球菌複合糖質ワクチン
WO2024233456A1 (en) 2023-05-05 2024-11-14 The Board Of Regents Of The University Of Oklahoma Variants of adrenomedullin (am) and adrenomedullin 2/intermedin (am2/imd) and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69032102T2 (de) 1989-08-15 1998-06-25 Massachusetts Inst Technology Stabilisierte impfstoffzusammensetzungen
US5728386A (en) 1993-12-21 1998-03-17 Merck & Co., Inc. Thermostable varicella zoster virus
CA2274755A1 (en) 1996-12-20 1998-07-02 Su-Pi Sheu Stabilizers for lyophilized vaccines
CN1053590C (zh) 1998-10-19 2000-06-21 卫生部长春生物制品研究所 冻干甲型肝炎减毒活疫苗及其保护剂
ATE400296T1 (de) 1999-12-02 2008-07-15 Novartis Vaccines & Diagnostic Zusammensetzungen und methoden zur stabilisierung von biologischen molekülen nach lyophilisierung
CN101678094B (zh) * 2007-06-04 2014-08-27 诺华股份有限公司 脑膜炎疫苗制剂
JP5701058B2 (ja) * 2007-10-19 2015-04-15 ノバルティス アーゲー 髄膜炎菌ワクチン処方物
BRPI0800357A2 (pt) 2008-03-10 2009-10-27 Fundacao Oswaldo Cruz método para produção de uma vacina estabilizada
CA2793510A1 (en) * 2010-03-18 2012-02-16 Novartis Ag Adjuvanted vaccines for serogroup b meningococcus

Also Published As

Publication number Publication date
US9283270B2 (en) 2016-03-15
US20130209503A1 (en) 2013-08-15

Similar Documents

Publication Publication Date Title
BR122020002986A2 (en:Method)
BR112014017635A2 (en:Method)
BR112014020069A2 (en:Method)
BR112014017614A2 (en:Method)
BR112014017625A2 (en:Method)
BR112014017659A2 (en:Method)
BR112014017646A2 (en:Method)
BR112014017607A2 (en:Method)
BR112014023589A2 (en:Method)
BR112014017638A2 (en:Method)
BR112013027865A2 (en:Method)
BR112014017609A2 (en:Method)
BR112014019239A2 (en:Method)
BR112014017634A2 (en:Method)
BR112014017644A2 (en:Method)
BR112014017618A2 (en:Method)
BR112014017647A2 (en:Method)
BR112014017623A2 (en:Method)
BR112014017652A2 (en:Method)
BR112014017630A2 (en:Method)
BR112014017627A2 (en:Method)
IN2012MU00206A (en:Method)
BR112014017631A2 (en:Method)
BR112014017641A2 (en:Method)
BR112014017621A2 (en:Method)